Stock Buy Rating Maintained For This Arizona Based Biotech Company

SenesTech's Stock Target Upped to $3.5 by HC Wainwright & Co.: A Crucial Update for Investors.

This article includes affiliate links. If you purchase anything through these affiliated links, the author/website may earn a commission.

In a recent development that should be of significant interest to investors, HC Wainwright & Co., a leading investment banking firm, has maintained its 'Buy' rating on SenesTech (NASDAQ: SNES), while adjusting the pric…